| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/06/2000 | EP1057825A1 Isoflavane derivatives and immunopotentiating compositions containing the same |
| 12/06/2000 | EP1057820A1 Arylpiperazinylalkyl-3(2H)-pyridazinones as serotonin 5HT and dopamine D2 receptor agonists |
| 12/06/2000 | EP1057819A1 Phthalazine derivatives and remedies for erectile dysfunction |
| 12/06/2000 | EP1057815A1 Cyclic amide compounds |
| 12/06/2000 | EP1057814A1 Tetrahydrobenzindole derivatives |
| 12/06/2000 | EP1057813A1 Indole derivatives and medicinal compositions containing the same |
| 12/06/2000 | EP1057809A1 Carbonate derivatives of retinol, process for their preparation and utilisations |
| 12/06/2000 | EP1057488A1 Interleukin-6 production inhibitors |
| 12/06/2000 | EP1057487A1 Antimicrobial compositions with synergistic effect, drugs and remedies for digestive diseases containing the same, process for the production thereof and preparations associated therewith |
| 12/06/2000 | EP1057486A1 Use of drug combination for treating Glaucoma |
| 12/06/2000 | EP1057485A1 Potassium channel activators |
| 12/06/2000 | EP1057483A1 Composition comprising theanine |
| 12/06/2000 | EP1057482A1 Remedy for meniere disease |
| 12/06/2000 | EP1057480A2 Transdermal estrogen agonist-antagonist therapy |
| 12/06/2000 | EP1057479A1 Pharmaceutical tablet formulations for direct compression |
| 12/06/2000 | EP1057416A2 Soluble isoflavone composition and method for preparing the same |
| 12/06/2000 | EP1057033A1 Treating cancer |
| 12/06/2000 | EP1057032A2 Treating cancer |
| 12/06/2000 | EP1057031A1 Treating cancer |
| 12/06/2000 | EP1057030A2 Treating cancer |
| 12/06/2000 | EP1057029A2 Treating cancer |
| 12/06/2000 | EP1057028A1 Treating cancer |
| 12/06/2000 | EP1057027A2 Treating cancer |
| 12/06/2000 | EP1056877A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 12/06/2000 | EP1056844A1 Human receptor gpr14, and a method of finding agonist and antagonist to human and rat gpr14 |
| 12/06/2000 | EP1056843A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 12/06/2000 | EP1056770A1 Novel disulfides and thiol compounds |
| 12/06/2000 | EP1056769A1 15-methyl-cyclopropanosteroids and method for the production thereof |
| 12/06/2000 | EP1056768A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 12/06/2000 | EP1056761A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE |
| 12/06/2000 | EP1056760A1 36 human secreted proteins |
| 12/06/2000 | EP1056759A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
| 12/06/2000 | EP1056754A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone |
| 12/06/2000 | EP1056749A1 NOVEL TRIAZOLO(4,5-d)PYRIMIDINE COMPOUNDS |
| 12/06/2000 | EP1056748A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 12/06/2000 | EP1056747A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 12/06/2000 | EP1056746A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 12/06/2000 | EP1056745A2 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines |
| 12/06/2000 | EP1056744A1 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines |
| 12/06/2000 | EP1056743A1 Benzamine derivatives |
| 12/06/2000 | EP1056742A1 Anti-viral pyrimidine derivatives |
| 12/06/2000 | EP1056737A1 Process for the preparation of simvastatin and derivatives thereof |
| 12/06/2000 | EP1056736A1 Alternate method for acylating 10-deacetylbaccatin iii selectively at the c-10 position |
| 12/06/2000 | EP1056733A1 Histamine h3 receptor ligands |
| 12/06/2000 | EP1056732A2 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases |
| 12/06/2000 | EP1056731A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone |
| 12/06/2000 | EP1056730A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone |
| 12/06/2000 | EP1056729A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia |
| 12/06/2000 | EP1056725A1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 12/06/2000 | EP1056724A2 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
| 12/06/2000 | EP1056722A1 Bisulfate salt of hiv protease inhibitor |
| 12/06/2000 | EP1056720A1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia |
| 12/06/2000 | EP1056719A2 Inhibitors of phospholipase enzymes |
| 12/06/2000 | EP1056718A1 Anti-retroviral functionalised aromatic compounds |
| 12/06/2000 | EP1056716A1 Cyclohexanediole derivatives |
| 12/06/2000 | EP1056714A1 Phenylalanine derivatives as inhibitors of alpha4 integrins |
| 12/06/2000 | EP1056710A1 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same |
| 12/06/2000 | EP1056705A1 Stable hyperforin salts, method for producing same and their use in the treatment of alzheimer's disease |
| 12/06/2000 | EP1056704A1 Antitumor agents |
| 12/06/2000 | EP1056701A1 E-2- 4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof |
| 12/06/2000 | EP1056700A1 Medicinal uses of phenylalkanols and derivates |
| 12/06/2000 | EP1056484A1 Products comprising fibrinogen for use in therapy |
| 12/06/2000 | EP1056476A1 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions |
| 12/06/2000 | EP1056475A1 Dendrimeric fullerene derivatives, method for producing same and their use as neuroprotectors |
| 12/06/2000 | EP1056469A1 Novel peptide copolymer compositions |
| 12/06/2000 | EP1056467A2 Method for the treatment of diseases or disorders of the inner ear |
| 12/06/2000 | EP1056464A1 L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage |
| 12/06/2000 | EP1056462A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 12/06/2000 | EP1056461A1 Method and means for treating glomerulonephritis |
| 12/06/2000 | EP1056460A1 Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system |
| 12/06/2000 | EP1056459A1 Treatment of hiv infections |
| 12/06/2000 | EP1056458A1 Method for the treatment of pain, including chronic and female specific pain |
| 12/06/2000 | EP1056457A1 S-lansoprazole compositions and methods |
| 12/06/2000 | EP1056455A1 Epimorphian compound and its use |
| 12/06/2000 | EP1056454A1 Use of macrolide compounds for treating glaucoma |
| 12/06/2000 | EP1056453A1 Use of epothilones for the treatment of cancer |
| 12/06/2000 | EP1056452A1 Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 12/06/2000 | EP1056451A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors |
| 12/06/2000 | EP1056450A1 Farnesyl-protein transferase inhibitors |
| 12/06/2000 | EP1056449A2 20-hete antagonists and agonists |
| 12/06/2000 | EP1056448A1 Pharmaceutical combinations containing tramadol |
| 12/06/2000 | EP1056447A1 Use of deprenyl compounds to treat viral infections and reduce tissue damage associated therewith |
| 12/06/2000 | EP1056446A1 Anticonvulsant drugs and pharmaceutical compositions thereof |
| 12/06/2000 | EP1056445A1 Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent |
| 12/06/2000 | EP1056444A1 Stable shaped particles of crystalline organic compounds |
| 12/06/2000 | EP1056443A1 Butorphanol sustained release formulations |
| 12/06/2000 | EP1056442A1 Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
| 12/06/2000 | EP1056419A1 Treatment of female sexual dysfunction |
| 12/06/2000 | EP1056359A1 Product and method to reduce stress induced immune suppression |
| 12/06/2000 | EP1056358A1 Use of d-tagatose as a prebiotic food component |
| 12/06/2000 | EP1056357A1 Calorically dense nutritional composition |
| 12/06/2000 | EP0777458B1 Control of hair growth |
| 12/06/2000 | EP0775692B1 Guanidinomethyl cyclohexane carboxylic ester derivative |
| 12/06/2000 | EP0751762B1 Skin care product |
| 12/06/2000 | EP0683670B1 Wound-healing compositions containing iodine and a sugar |
| 12/06/2000 | EP0680317A4 Method for treating a medical patient for cardiac trauma |
| 12/06/2000 | EP0675733B1 Peptide-carbohydrate conjugates generating t-cell immunity |
| 12/06/2000 | EP0597088B1 Novel imidazole derivatives, their preparation and therapeutic applications |
| 12/06/2000 | EP0591303B1 Methods and compositions for treating malaria and other diseases |
| 12/06/2000 | CN1275989A Bile acid salts of metals with physiological action and the use thereof in therapy |